Product Program year 2025 Source: CMS Open Payments

Biodesign

Device Otolaryngology/head And Neck Surgery

PDI 10827002444512

Open in the dashboard

General payments

$69,351

155 payments

Research payments

$154,847

23 payments

Through program year 2025, $69,351 in general payments and $154,847 in research payments were reported against Biodesign (Otolaryngology/head And Neck Surgery).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2025 Research $37,615 12
2023 General $738 34
2023 Research $51,989 9
2022 General $38,369 75
2021 General $30,243 46
2021 Research $65,242 2

Breakdown

Who paid General payments · program years 2021–2023
  1. Cook Medical LLC $38,967 129 payments
  2. Cook Incorporated $29,782 14 payments
  3. Cook Biotech Incorporated $602 12 payments
Top recipients General payments · program year 2023
  1. Shane Griffith Otolaryngology · Brunswick, ME $68 9% · 1 payment
  2. Gabriel Arom Pediatric Otolaryngology · Orange, CA $56 8% · 1 payment
  3. Gabriel Gomez Pediatric Otolaryngology · Houston, TX $56 8% · 1 payment
  4. Michael Newman Plastic and Reconstructive Surgery · Torrance, CA $32 4% · 1 payment
  5. Jeffrey Suh Otolaryngology · Los Angeles, CA $29 4% · 1 payment

The top 5 of 34 recipients; each share is of general payments naming this product in 2023.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2023
  1. Otolaryngology $475 64% · 24 practitioners
  2. Pediatric Otolaryngology Otolaryngology $139 19% · 3 practitioners
  3. Plastic and Reconstructive Surgery Surgery $32 4% · 1 practitioner
  4. Otology & Neurotology Otolaryngology $19 3% · 1 practitioner
  5. Otolaryngology/Facial Plastic Surgery Otolaryngology $17 2% · 1 practitioner

The top 5 of 9 specialties; each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2023
  1. California $233 32% · 7 recipients
  2. Texas $135 18% · 8 recipients
  3. Oklahoma $131 18% · 7 recipients
  4. Louisiana $90 12% · 6 recipients
  5. Maine $68 9% · 1 recipient

The top 5 of 8 states; each share is of general payments naming this product in 2023 where a state was reported.

The top 25 states, free in the app

155 general · 23 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record